Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction

American Journal of Cardiology

Volumn 79, Issue 5, 1997, Pages 564-569

  Bonaduce, Domenico ^a,b   Petretta, Mario ^a   Lanniciello, Angiolino ^a   Apicella, Claudio ^a   Cavallaro, Vincenzo ^a   Marciano, Fortunate ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; FELODIPINE; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FREQUENCY MODULATION; HEART RATE; HOLTER MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; ELECTROCARDIOGRAPHY, AMBULATORY; FELODIPINE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SINGLE-BLIND METHOD; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VERAPAMIL;

EID: 0030900666     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00816-8     Document Type: Article

References (30)

1. Yusuf S. Verapamil following uncomplicated myocardial infarction: promising but not proven. Am J Cardiol 1996;77:421-422.
2. Bonaduce D, Marciano F, Petretta M, Migaux ML, Morgano G, Bianchi V, Salemme L, Valva G, Condorelli M. Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation 1994;90:108-113.
3. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
4. von Neumann J, Kent RH, Bellinson HR, Hart BI. The mean square successive difference. Ann Math Stat 1941;12:153-162.
5. Bendath JS, Piersol AG. Random Data: Analysis and Measurement Procedures. New York: John Wiley-Interscience. 1971;322-330.
6. Berger RD, Akselrod S, Gordon D, Cohen RJ. An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng 1986;33:900-904.
7. Marciano F, Mazzarella M, Migaux ML. Performance evaluation of a Holter recordings computer analysis system. Comput Cardiol 1981;8:523-526.
8. Marciano F, Mazzarella M, Migaux ML. A signal processor system for the analysis of EEG and ECG recordings. Proceedings ISMM Symposium: Micro-computer Applications in Medicine and Bioengineering. Anaheim, California: Acta Press, 1985;10-14.
9. Norusis MJ. SPSS for Windows. Advanced Statistics, Release 6.0. Chicago: SPSS Inc., 1993;31-56.
10. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
11. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171.
12. Cripps TR, Malik M, Farrell TG, Camm AJ. Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method. Br Heart J 1991;65:14-19.
13. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol 1991;18:1643-1649.
14. Bekheit S, Tangella M, el-Sakr A, Rasheed Q, Craelius W, EL-Sherif N. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990;119:79-85.
15. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interactions in man and conscious dog. Circ Res 1986;59:178-193.
16. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
17. Koizumi K, Terui N, Kollai M. Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic regulation. J Auton Nerv Syst 1985;12:251-259.
18. Bernardi L, Leuzzi S, Radaelli A, Passino C, Johnston JA, Sleight P. Lowfrequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: a baroreceptor or central phenomenon? Clin Sci 1994;87:649-654.
19. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996;27:1053-1060.
20. Blychert E, Wingstrand K, Edgar B, Lidman K. Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets. Br J Clin Pharmac 1990;29:39-45.
21. Myers MG. Dihydropyridine calcium antagonists and the trough:peak ratio: focus on adverse effects. J Hypertens 1994;12(suppl 8):S73-S77.
22. Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, Adegbile IA, O'Connor DT. Divergent effects of dihydropyridine and phenilalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension 1995;26:143-149.
23. Yusuf S. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Circulation 1995;92:1079-1082.
24. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
25. Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 1991;67:1295-1297.
26. Rengo F, Carbonin P, Pahor M, De Caprio L, Bernabei R, Ferrara N, Carosella L, Acanfora D, Parlati S, Vitale D, and the CRIS Investigators. A controlled trial of verapamil in patients after acute myocardial infarction: results of the Calcium Antagonist Reinfarction Italian Study (CRIS). Am J Cardiol 1996;77:365-369.
27. Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990;66:779-785.
28. Mølgaard H, Mickley H, Pless P, Bjerregaard P, Davis BR, Møller M. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993;71:1357-1359.
29. Sandrone G, Mortara A, Torzillo D, La Rovere MT, Malliani A, Lombardi F. Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol 1994;74:340-345.
30. Multicenter Diltiazem Post-infarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.